|
Re: Modulating ZEN‐3694 and Enzalutamide Combination Dosing in a Metastatic Prostate Cancer Patient Using CURATE.AI, an Artificial Intelligence Platform
|
5
|
Zenith Epigenetics
|
Sep 02, 2018 12:27PM
|
|
Re: Monday!
|
4
|
Resverlogix Corp.
|
Sep 26, 2019 08:01PM
|
|
Re: Monday!
|
5
|
Resverlogix Corp.
|
Sep 26, 2019 09:31PM
|
|
Re: Monday!
|
3
|
Resverlogix Corp.
|
Sep 26, 2019 10:15PM
|
|
Re: Monday!
|
2
|
Resverlogix Corp.
|
Sep 27, 2019 08:27AM
|
|
Re: Monday!
|
4
|
Resverlogix Corp.
|
Sep 27, 2019 08:54AM
|
|
Re: Monday!
|
3
|
Resverlogix Corp.
|
Sep 27, 2019 10:38AM
|
|
Re: Month 10
|
3
|
Zenith Epigenetics
|
Apr 18, 2017 12:08PM
|
|
Re: More Hub Leaders will be needed me thinks
|
3
|
Resverlogix Corp.
|
Jun 21, 2017 02:52PM
|
|
Re: More In Financial Post Today March 29
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 30, 2016 10:28AM
|
|
Re: More news on the way? They say things happen in 3s.....
|
5
|
Resverlogix Corp.
|
May 24, 2017 10:31AM
|
|
Re: More sites now recruiting for ZEN003694 NCT02705469 trial
|
2
|
Zenith Epigenetics
|
Jun 09, 2016 02:31PM
|
|
Re: More Than Just DSMB Green Light
|
7
|
Resverlogix Corp.
|
Nov 01, 2017 01:18PM
|
|
Re: More Than Just DSMB Green Light
|
2
|
Resverlogix Corp.
|
Nov 01, 2017 03:12PM
|
|
Re: More Than Just DSMB Green Light
|
2
|
Resverlogix Corp.
|
Nov 01, 2017 04:11PM
|
|
Re: Motley Fool - Resverlogix one of three biotechs than can "Electrify your TFSA"
|
2
|
Resverlogix Corp.
|
Jun 24, 2018 12:00PM
|
|
Re: Move Conversation To The "Uninteresting Forum"
|
6
|
Resverlogix Corp.
|
Sep 13, 2017 05:24PM
|
|
Re: Mr. Paradis' Smoke Screen
|
3
|
Resverlogix Corp.
|
Jul 29, 2016 06:45PM
|
|
Re: Must be a dilutive financing in the works...
|
2
|
Resverlogix Corp.
|
Oct 18, 2018 09:53AM
|
|
Re: Must be a dilutive financing in the works...
|
1
|
Resverlogix Corp.
|
Oct 18, 2018 11:32AM
|
